Browse All
Displaying 1 - 2 of 2
Author:Harris, Sarah Vermersch, Patrick Montalban, Xavier Hartung, Hans-Peter Kappos, Ludwig Southworth, Harry Sheffield, James K. Silva, Diego Cohen, Jeffrey A.
Session Name:P1: MS Biomarkers
Topic:MS and Inflammatory Disease
Program Number:P1.012
Author Institution:Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Univ. Lille, Inserm UMR U1172, CHU Lille, FHU Precise, Lille, France, Lille, France Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Sydney, Australia Department of Neurology, Medical University of Vienna, Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Data Clarity Consulting Ltd, Stockport, England, United Kingdom, England, United Kingdom Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Session Name:P7: MS Therapeutics 1
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
